CVS Health Corporation
CVSHealthcareNASDAQHealthcare Plans
Scan Results
Daily timeframeCVS Health Corporation provides health solutions in the United States. The company carries a $137.12B market cap, placing it firmly in the large-cap category. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Market Cap
$137.12B
Beta
0.60
P/E (TTM)
46.73
P/E (Fwd)
12.78
EPS (TTM)
$2.30
EPS (Fwd)
$8.41
ROE
3.8%
ROA
2.7%
Cash
$11.80B
Total Debt
$78.35B
Free CF
$5.20B
52W Change
73.5%
Annual Financials
Cash vs Debt
CVS Health Corporation carries $78.35B in total debt against $11.80B in cash reserves — debt is roughly 6.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $5.20B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 3.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $322.47B (2022) to $402.07B (2025), reflecting a 25% increase over the period.
The relatively low beta of 0.60 suggests CVS is a less volatile holding compared to the broader index. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence CVS Health Corporation's trajectory.